The serotonin receptor antagonist and reuptake inhibitor trazodone reduces neuroinflammation mediated by MG and NLRP3 inflammasome activation, thereby alleviating memory and sleep disturbances (Ising et al., 2019). Here, NLRP3 is linked to myasthenia gravis.